OTC · Financial Statements
BioSyntech, Inc. (BSYI) Financial Statements
$0.00
OTC: BSYI
Market Cap $229033
Overview Financials Dividend BioSyntech, Inc. most recently reported annual revenue of $0, a net loss of $13.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2004 2005 2006 2007 2008 Revenue $0 $0 $0 $0 $0 Operating Profit $-5.0M $-6.0M $-7.0M $-9.0M $-11.0M Net Profit $-5.0M $-7.0M $-8.0M $-9.0M $-13.0M EPS $-0.14 $-0.17 $-0.09 $-0.10 $-0.13 Op Margin -2685.2% -10349.0% -2996.2% -3358.0% -27056.3%
Balance Sheet (USD)
Metric 2004 2005 2006 2007 2008 Total Assets $5.0M $15.0M $16.0M $6.0M $7.0M Total Liabilities $7.0M $6.0M $5.0M $4.0M $14.0M Cash $1.0M $5.0M $4.0M $3.0M $4.0M Borrowings $6.0M $2.0M $4.0M $3.0M $12.0M
Cash Flow (USD)
Metric 2004 2005 2006 2007 2008 Operating Cash Flow $-4.0M $-6.0M $-8.0M $-8.0M $-10.0M Investing Cash Flow $1.0M $-7.0M $-2.0M $8.0M $0 Financing Cash Flow $0 $-1.0M $-1.0M $0 $-1.0M Net Cash Flow $-1.0M $4.0M $-1.0M $-1.0M $1.0M Free Cash Flow $-4.0M $-6.0M $-8.0M $-9.0M $-10.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.81 FCF Yield -3054.11% Quick Ratio 0.45 Interest Coverage -43.09 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .